Improving How Blood Platelets Are Stored

This patent describes new chemical compounds and methods to prevent damage to blood platelets when they are stored, like in blood banks, making them last longer and more effective for transfusions.

What it covers

The patent introduces specific chemical compounds, referred to as 'formula I,' and compositions containing them. These compounds are designed to slow, prevent, or even reverse damage to platelets. This damage often happens during blood banking or when platelets are kept cold. By using these compounds, the patent aims to improve how long platelets survive after being transfused into a patient. For example, a blood bank could add these special compounds to bags of platelets before refrigeration to ensure they remain viable for a longer period.

What it doesn't cover

• —Does not cover methods for storing whole blood or other blood components like red blood cells or plasma.
• —Does not cover methods of platelet storage that do not involve the specific chemical compounds described by 'formula I'.
• —Does not cover diagnostic methods for assessing platelet damage or viability.
• —Does not cover treatments for platelet disorders that are not related to storage damage.

The clever bit

The novelty lies in identifying specific chemical structures (compounds according to 'formula I') that can effectively protect platelets from common storage-related damage, particularly cold-induced injury, without negatively affecting their crucial function upon transfusion. This precise chemical intervention aims to overcome a long-standing challenge in blood banking.

Why it matters

Platelets are essential for blood clotting and are frequently needed by patients with cancer, severe injuries, or those undergoing major surgery. However, platelets have a very short shelf life, typically only 5-7 days, even with current storage techniques. This short window often leads to waste and can make it challenging to maintain a sufficient supply. This patent aims to extend that shelf life, which could significantly reduce waste and ensure more platelets are available when critically needed.

Real-world examples

• 1.Blood banks
• 2.Hospitals performing transfusions
• 3.Trauma centers
• 4.Cancer treatment facilities
• 5.Military field hospitals